GRAINGER DAVID J - Insider Non-Derivative Transactions at Centessa Pharmaceuticals plc (CNTA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 31, 2023, GRAINGER DAVID J's relationship to Centessa Pharmaceuticals plc (CNTA) is Officer (Chief Innovation Officer), and currently has 962,790 shares of Ordinary Shares.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CNTA insiders.
Data Source: SEC.
GRAINGER DAVID J - Insider Non-Derivative Transactions of CNTA Ordinary Shares
GRAINGER DAVID J - Insider Non-Derivative Transactions at CNTA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 1, 2024 | F -- (Ordinary Shares) | 4700 | 7.96 | 962790 |
| Oct 1, 2023 | F -- (Ordinary Shares) | 4700 | 6.47 | 967490 |
| Jul 1, 2023 | F -- (Ordinary Shares) | 4290 | 5.9 | 972190 |
| Apr 1, 2023 | F -- (Ordinary Shares) | 4825 | 3.9 | 976480 |
| Feb 2, 2023 | Acquisition -- (Ordinary Shares) | 77200 | 0 | 981305 |
| Jan 1, 2023 | F -- (Ordinary Shares) | 2497 | 3.1 | 911259 |
| Oct 1, 2022 | F -- (Ordinary Shares) | 7154 | 4.25 | 906602 |